A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma

Clinical trial NCT00283439 · COMPLETED

Trial details

NCT number: NCT00283439
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chemotherapy-Induced Thrombocytopenia Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Cancer Oncology Thrombocytopenia

Start date: 2005-10-01
Primary completion: 2008-05-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.